Worth noting:

News from Recordati on osilodrostat for endogenous Cushing’s – More details here

Corcept Therapeutics reports significant results in Cushing’s drug trial.  Read more

New support site from Chiesi; Rethink acromegaly

Crinetics Pharmaceuticals announces more Phase 3 paltusotine results in participants with acromegaly who were not pharmacologically treated . Read more

Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.

Chiesi relaunches a patient-facing website for Mycapssa.

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

Live Talk on Demand

Today's podcast covers my conversation with Jill Sisco, president of the Acromegaly Community, about the recent meetings with the Food and Drug Administration (FDA), the US governmental entity responsible for approving new medications.  Our conversation focuses on the original meeting held in 2021 and a recent listening session where the AC provided additional feedback to the FDA.  

Listen in your favorite platform